100 related articles for article (PubMed ID: 16793718)
21. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
Zhong RK; Lane TA; Ball ED
Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
[TBL] [Abstract][Full Text] [Related]
22. [Examination of interleukin levels and growth factor from blood platelets in leukemia].
Kiersnowska-Rogowska B; Rogowski F; Petelski T; Citko A; Jaroszewicz E; Bielawiec M
Pol Tyg Lek; 1996 May; 51(19-22):281-2, 288. PubMed ID: 9289710
[TBL] [Abstract][Full Text] [Related]
23. The biological characteristics of dendritic cells derived in vitro from myelogeneous leukemia cells and healthy donor cells.
Tong XM; Yao HP; Qian WB; Zhu LF; Fu ZH; Huang ZL; Jin J
Int J Lab Hematol; 2008 Oct; 30(5):372-81. PubMed ID: 18205840
[TBL] [Abstract][Full Text] [Related]
24. Effects of angiogenic regulators on in vitro proliferation and cytokine secretion by native human acute myelogenous leukemia blasts.
Bruserud Ø; Glenjen N; Ryningen A
Eur J Haematol; 2003 Jul; 71(1):9-17. PubMed ID: 12801293
[TBL] [Abstract][Full Text] [Related]
25. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis.
Amirkhosravi A; Amaya M; Siddiqui F; Biggerstaff JP; Meyer TV; Francis JL
Platelets; 1999; 10(5):285-92. PubMed ID: 16801104
[TBL] [Abstract][Full Text] [Related]
26. Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.
de Jonge HJ; Weidenaar AC; Ter Elst A; Boezen HM; Scherpen FJ; Bouma-Ter Steege JC; Kaspers GJ; Goemans BF; Creutzig U; Zimmermann M; Kamps WA; de Bont ES
Clin Cancer Res; 2008 Feb; 14(3):924-30. PubMed ID: 18245556
[TBL] [Abstract][Full Text] [Related]
27. In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines.
Bruserud O; Gjertsen BT; von Volkman HL
J Hematother Stem Cell Res; 2000 Dec; 9(6):923-32. PubMed ID: 11177606
[TBL] [Abstract][Full Text] [Related]
28. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches.
Bruserud O; Gjertsen BT; Foss B; Huang TS
Stem Cells; 2001; 19(1):1-11. PubMed ID: 11209086
[TBL] [Abstract][Full Text] [Related]
29. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
30. Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators.
Hatfield K; Øyan AM; Ersvaer E; Kalland KH; Lassalle P; Gjertsen BT; Bruserud Ø
Br J Haematol; 2009 Jan; 144(1):53-68. PubMed ID: 19016730
[TBL] [Abstract][Full Text] [Related]
31. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
Riccioni R; Diverio D; Mariani G; Buffolino S; Riti V; Saulle E; Petrucci E; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
Stem Cells; 2007 Aug; 25(8):1862-71. PubMed ID: 17446561
[TBL] [Abstract][Full Text] [Related]
32. An acquired form of Bernard Soulier syndrome associated with acute myeloid leukemia.
Aziz KA
Saudi Med J; 2005 Jul; 26(7):1095-8. PubMed ID: 16047060
[TBL] [Abstract][Full Text] [Related]
33. In vitro culture of acute myelogenous leukemia blasts: a comparison of four different culture media.
Bruserud O; Frostad S; Foss B
J Hematother; 1999 Feb; 8(1):63-73. PubMed ID: 10192303
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
35. In vitro tumoricidal activity of immunoadsorbed leukemic serum.
Miller WJ; Branda RF
J Biol Response Mod; 1984; 3(3):231-4. PubMed ID: 6379106
[TBL] [Abstract][Full Text] [Related]
36. Functional platelet-activating factor receptors in immature forms of leukemic blasts.
Reynaud S; Malissein E; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
Leuk Res; 2007 Mar; 31(3):399-402. PubMed ID: 16837045
[TBL] [Abstract][Full Text] [Related]
37. Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.
Gyurkocza B; Plescia J; Raskett CM; Garlick DS; Lowry PA; Carter BZ; Andreeff M; Meli M; Colombo G; Altieri DC
J Natl Cancer Inst; 2006 Aug; 98(15):1068-77. PubMed ID: 16882944
[TBL] [Abstract][Full Text] [Related]
38. Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells.
Wahlström O; Linder C; Kalén A; Magnusson P
Platelets; 2007 Mar; 18(2):113-8. PubMed ID: 17365859
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
[TBL] [Abstract][Full Text] [Related]
40. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
